• γH2AX DNA Damage Detection Kit: Precision DNA Damage Monitor

  2026-05-15

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO delivers sensitive, reproducible detection of DNA double-strand breaks across diverse research applications. This article details optimized workflows, troubleshooting strategies, and integration with cutting-edge radiosensitizer studies to empower high-content DNA damage and repair assays.

• Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso

  2026-05-14

  Oligo (dT) 25 Beads provide researchers with a reliable solution for isolating polyadenylated mRNA from eukaryotic samples using superparamagnetic bead technology. This product is ideal for workflows requiring high-purity mRNA for applications like cDNA synthesis and RT-PCR, but should not be used for prokaryotic RNA or non-polyadenylated transcripts.

• Catalpol’s Protective Effects in Cardio-Cerebrovascular Dise

  2026-05-14

  This review systematically evaluates catalpol, an iridoid glucoside from Rehmannia glutinosa, for its multifaceted protective roles in cardio-cerebrovascular diseases (CVDs). By dissecting molecular mechanisms and preclinical findings, it highlights catalpol’s potential as a research tool and therapeutic candidate for conditions such as atherosclerosis, myocardial ischemia, and heart failure.

• Cholesterol Impedes Endosomal Trafficking of Lipid Nanoparti

  2026-05-13

  This study dissects how cholesterol content in lipid nanoparticles (LNPs) hinders their intracellular trafficking and delivery efficiency by promoting the trapping of nucleic acids in peripheral early endosomes. Using a high-sensitivity imaging platform, the research provides key mechanistic insights for optimizing LNP formulations in nucleic acid delivery applications.

• Arrb2-Induced M2 Macrophage Polarization Limits Hepatic IRI

  2026-05-13

  This study uncovers a hepatocyte-driven immunometabolic mechanism wherein Arrb2 upregulates 6-ketoLCA to promote M2 macrophage polarization, significantly reducing hepatic ischemia–reperfusion injury (IRI) in mouse models. These findings provide a mechanistic basis for targeted modulation of liver immune responses, potentially informing future strategies in transplantation research.

• Ultra-Sensitive ECL Detection: Advancing Low-Abundance Prote

  2026-05-12

  Explore how hypersensitive ECL chemiluminescent detection transforms immunoblotting for low-abundance protein targets. We bridge mechanistic insights, including ferroptosis-linked neuronal cell death, with strategic guidance for translational researchers. This article integrates primary literature, competitive analyses, and protocol intelligence—providing a visionary outlook for those pushing the boundaries of protein detection.

• Structure-Based Discovery of NSP15 Inhibitors in SARS-CoV-2

  2026-05-12

  This study leveraged structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease implicated in immune evasion. The findings highlight new antiviral strategies targeting non-structural proteins and inform future inhibitor design for pandemic response.

• Optimizing Immunoproteasome Studies with ONX-0914 (PR-957)

  2026-05-11

  This scenario-driven guide explores how ONX-0914 (PR-957) (SKU A4011) from APExBIO addresses real laboratory challenges in immunoproteasome inhibition research. Integrating evidence-based Q&A, protocol parameters, and vendor selection considerations, the article empowers biomedical scientists to achieve reproducible, high-fidelity results in cytokine blockade, autoimmune modeling, and cell-based assays.

• Pam3CSK4 (SKU A9920): Reliable TLR1/2 Agonist for Immune Ass

  2026-05-11

  This article explores real-world laboratory challenges in immune cell activation and inflammation modeling, demonstrating how Pam3CSK4 (SKU A9920) delivers robust, reproducible results. Integrating scenario-driven Q&A, protocol guidelines, and comparative analysis, it highlights why Pam3CSK4 is a trusted choice for TLR1/2 pathway studies.

• Calpeptin: Calpain Inhibitor Workflows for Fibrosis Research

  2026-05-10

  Calpeptin enables precision modulation of calpain-driven pathways, delivering nanomolar potency in both cellular and animal models of fibrosis and inflammation. This guide breaks down experimental workflows, troubleshooting strategies, and evidence-based best practices for researchers optimizing calpain inhibition in translational studies.

• Hetero-Galactan from S. vaninii Targets TLR4/NF-κB for Lipid

  2026-05-09

  This study reports the structural characterization and hypolipidemic effects of a novel hetero-galactan (SVP3) from Sanghuangporus vaninii. SVP3 acts by modulating the TLR4/NF-κB pathway, reducing lipid accumulation, inflammation, and hepatic injury in a mouse model, highlighting its potential as a low-toxicity therapeutic lead for hyperlipidemia.

• Ferroptosis-Related Gene Signature and Atorvastatin in HCC P

  2026-05-08

  This study introduces a novel prognostic model based on ferroptosis-related genes for hepatocellular carcinoma (HCC), identifying Atorvastatin as a candidate agent capable of inducing ferroptosis and inhibiting HCC cell growth and migration. The findings support the integration of ferroptosis modulation and HMG-CoA reductase inhibition in liver cancer research, with practical implications for experimental design and therapeutic development.

• Liproxstatin-1: Expanding Ferroptosis Inhibitor Utility Beyo

  2026-05-08

  Explore how Liproxstatin-1, a potent ferroptosis inhibitor, enables new frontiers in oxidative stress and glandular dysfunction research. This article offers a deep dive into unique mechanisms, assay considerations, and translational implications distinct from standard renal or cancer models.

• ECL Chemiluminescent Substrate Detection Kit: Pushing Bounda

  2026-05-07

  Explore how the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables advanced horseradish peroxidase (HRP) chemiluminescence and sets new standards in low-abundance protein analysis. Dive deeper into practical assay optimization and translational insights not found in other reviews.

• Advanced Strategies with ECL Chemiluminescent Substrate Dete

  2026-05-07

  Explore how the ECL Chemiluminescent Substrate Detection Kit empowers ultra-sensitive, low-background immunoblotting. This article uniquely bridges mechanistic insights from tumor metabolism research to practical assay optimization, offering evidence-based guidance for HRP chemiluminescence workflows.

15725 records 1/1049 page Next 12345 下5页 Last page